OMBAKAY
Live / Applied — Third extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 02 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98388293
- Mark type
- Stylized text
- Filed
- 02 Feb 2024
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Kristen Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders
Owner
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
Prosecution history
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 3 GRANTED
- 16 Mar 2026 — SOU EXTENSION 3 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2025 — SOU EXTENSION 2 GRANTED
- 08 Sept 2025 — SOU EXTENSION 2 FILED
- 08 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 1 GRANTED
- 10 Apr 2025 — SOU EXTENSION 1 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION